Filing Details

Accession Number:
0000886163-14-000081
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-01 12:16:14
Reporting Period:
2014-06-30
Filing Date:
2014-07-01
Accepted Time:
2014-07-01 12:16:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237556 W Matthew Foehr 11119 North Torrey Pines Road, Suite 200
La Jolla CA 92037
Evp And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-30 428 $43.79 53,885 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Shares Acquired under Ligand's employee stock purchase plan.